SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-009996
Filing Date
2020-10-22
Accepted
2020-10-22 14:59:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27634
2 filename2.txt TEXT-EXTRACT 1430
  Complete submission text file 0000000000-20-009996.txt   40194
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filed for) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences